Skip to main content
https://www.highperformancecpmgate.com/rgeesizw1?key=a9d7b2ab045c91688419e8e18a006621

3D-printing company Formlabs expects its swabs to receive FDA exemption

Formlabs, the privately held, Massachusetts-based 3D-printing company, will soon receive an exemption from the U.S. Food and Drug Administration for its swab designed for use in COVID-19 test kits, TechCrunch has learned.

Global supply chains for test kit components including swabs and chemical reagents have hampered the ability of governments to increase testing to a point where they can adequately ascertain the scope of the outbreak of the novel coronavirus within their borders.

“Yesterday we got a notification from the FDA that this is going to be a class one exempt product,” said Formlabs chief product officer David Lakatos. “As long as it’s manufactured in an ISO 135 controlled facility.”

As cases are identified across the U.S., tests are flowing to the geographies where the disease has spread the fastest, leaving other parts of the country under-resourced to address what could be an increasing outbreak in other communities that have yet to receive a complete picture of the disease’s spread.

With swabs, the problem has been compounded that of the few manufacturers of the sorely needed test kit component, only one is in the U.S. while another is in Italy.

“About a week and a half ago we joined this effort,” says Lakatos.

Formlabs is uniquely positioned to scale up production he said, thanks in part to the 60,000 printers the company has on hand and the recent acquisition of a facility in Ohio that enables the company to make surgical-grade products.

The company is currently finishing up human trials and gearing up to expand capacity at its Ohio manufacturing facility. According to Lakatos, the company will be able to supply 100,000 swabs per day. “We are starting to print these,” Lakatos said. “But we won’t send anything out until we get the green light.”

Currently most of the swabs are earmarked for partner hospitals that worked with the company to develop the swabs, but the company is also working with large distributors to access their distribution channels and get the swabs into roughly 3,000 hospitals around the U.S.

“At the end of the day we’re just looking to get them out,” Lakatos said.

Comments

Popular posts from this blog

Uber co-founder Garrett Camp steps back from board director role

Uber co-founder Garrett Camp is relinquishing his role as a board director and switching to board observer — where he says he’ll focus on product strategy for the ride hailing giant. Camp made the announcement in a short Medium post in which he writes of his decade at Uber: “I’ve learned a lot, and realized that I’m most helpful when focused on product strategy & design, and this is where I’d like to focus going forward.” “I will continue to work with Dara [Khosrowshahi, Uber CEO] and the product and technology leadership teams to brainstorm new ideas, iterate on plans and designs, and continue to innovate at scale,” he adds. “We have a strong and diverse team in place, and I’m confident everyone will navigate well during these turbulent times.” The Canadian billionaire entrepreneur signs off by saying he’s looking forward to helping Uber “brainstorm the next big idea”. Camp hasn’t been short of ideas over his career in tech. He’s the co-founder of the web 2.0 recommendatio...

Leading VCs discuss how COVID-19 has impacted the world of digital health

In December 2019, Extra Crunch spoke to a group of investors leading the charge in health tech to discuss where they saw the most opportunity in the space leading into 2020 . At the time, respondents highlighted startups in digital therapeutics, telehealth and mental health that were improving medical practitioner efficiency or streamlining the distribution of care, amongst a variety of other digital health markets that were garnering the most attention. Where top VCs are investing in digital health In the months since, the COVID-19 crisis has debilitated national healthcare systems and the global economy. Weaknesses in healthcare systems have become clearer than ever, while startups and capital providers have struggled to operate while wide swaths of the market effectively shut down. Given significant volatility and the rapid changes seen in the worlds of healthcare, venture and startups broadly, we wanted to understand which inefficiencies might have been brought to light, w...

News-reading app Flipboard expands local coverage, including coronavirus updates, to 12 more U.S. metros

Earlier this year, personalized news aggregation app Flipboard expanded into local news . The feature brought local news, sports, real estate, weather, transportation news and more to 23 cities across the U.S. Today, Flipboard is bringing local news to 12 more U.S. metros and is adding critical coronavirus local coverage to all of the 35 supported locales. The 12 new metros include the following:  Baltimore, Charlotte, Cleveland, Detroit, Indianapolis, Nashville, Pittsburgh, Orlando, Raleigh, Salt Lake City, St. Louis, and Tampa Bay. They join the 23 cities that were already supported:  Atlanta, Austin, Boston, Chicago, Dallas, Denver, Houston, Las Vegas, Los Angeles, Miami, Minneapolis-St. Paul, New Orleans, New York City, Philadelphia, Phoenix, Portland, Sacramento, San Diego, San Francisco Bay Area, Seattle, Toronto, Vancouver and Washington, D.C. To offer local news in its app, Flipboard works with area partners, big and small, like The Plain Dealer’s Cleveland.com , ...